<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02060851</url>
  </required_header>
  <id_info>
    <org_study_id>kunshan002</org_study_id>
    <nct_id>NCT02060851</nct_id>
  </id_info>
  <brief_title>Effects of Early Short-term Intravenous Iron Supplements Combinded EPO in Preterm Infants</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kunshan First People's Hospital Affiliated to Jiangsu University</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kunshan First People's Hospital Affiliated to Jiangsu University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are wide variations in iron supplementation practices in NICU.Guidelines on paediatric
      Parenteral nutrition suggested the dose of 200Î¼g/kg.d iron by parenteral nutrition.In our
      early study serum ferritin and TIBC were not statistically significant before and after
      intervention by used the dose of intravenous iron.In our study,we find twhether iron combined
      EPO can improve iron state in preterm.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hematological evaluation</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Hematological evaluation including RBC, Hb, MCV, MCH, MCHC, RET, CRP were mesured before and after the intervention. The three groups were all peripheral blood.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Iron storage</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Iron storage evaluation including ferritin, serum iron, TIBC on the days were measured before and after the intervention.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">138</enrollment>
  <condition>Preterm Anemia</condition>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intravenous iron and EPO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no intravenous iron or EPO</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intravenous iton but no EPO</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron sucrose</intervention_name>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_label>group 2</arm_group_label>
    <other_name>Cosmofer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EPO</intervention_name>
    <arm_group_label>group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants with birth weight less than 2.5kg Have parenteral nutrition indication
             With written informed consent of parents or guardian

        Exclusion Criteria:

          -  Kidney and liver function abnormal have hemolytic disease have hemorrhagic disease
             have Serious congenital malformation have septicemia have plethora newborn use TPN
             less than ten days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hua Wang, MD</last_name>
    <phone>0512-57027091</phone>
    <email>mumeer@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kunshan First Hospital</name>
      <address>
        <city>Kunshan, ,</city>
        <state>Jiangsu</state>
        <zip>215300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Wang, MD</last_name>
      <phone>+8618913261020</phone>
      <email>mumeer@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2014</study_first_submitted>
  <study_first_submitted_qc>February 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <last_update_submitted>February 9, 2014</last_update_submitted>
  <last_update_submitted_qc>February 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kunshan First People's Hospital Affiliated to Jiangsu University</investigator_affiliation>
    <investigator_full_name>Wang Hua</investigator_full_name>
    <investigator_title>Ethics Committee of Kunshan First People's Hospital</investigator_title>
  </responsible_party>
  <keyword>EPO</keyword>
  <keyword>Intravenous iron</keyword>
  <keyword>iron storage</keyword>
  <keyword>preterm anemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ferric oxide, saccharated</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

